A report in Moscow Times confirms that the developers of Russia’s Sputnik V Coronavirus vaccine are studying the jab’s effectiveness against the so-called “Moscow strain” of the virus.
Daily Current Affairs Quiz 2021
Sputnik V is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Sputnik V is a two-component vaccine in which adenovirus serotypes 5 and 26 are used. A fragment of tissue-type plasminogen activator is not used, and the antigen insert is an unmodified full-length S-protein. Sputnik V vaccine is produced with the HEK293 cell line.
